ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

AURORA CANNABIS INC

Financials through Q4 FY2025, quarter ended Mar 31, 2025Last filing: 40-F on Jun 11, 2026

$3.96−0.03 (-0.75%)

Close on Oct 19, 2026

Community

Notes and questions about Aurora Cannabis from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Aurora Cannabis's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Feb 20, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACB.

Revenue growth55.1% · median 22.1%

Gross margin54.6% · median 35.5%

Operating margin1.4% · median -28.1%

Advertisement
300 × 250